Back to Companies
COLLEGIUM PHARMACEUTICAL, INC
COLLNasdaqCIK: 0001267565
Over the 16 most recent insider filings, COLLEGIUM PHARMACEUTICAL, INC (COLL) has seen activity from 9 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $8.1M sold, net sales of $8.1M. Dreyer Scott is the most active by dollar volume, and the single largest transaction was $2.0M by Dreyer Scott. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$10.9M
Purchases
$0
Sales
$8.1M
Unique Insiders
9
Recent Insider Trades
16 loaded
| Jun 10 | COLL COLLEGIUM PHARMACEUTICAL, INC | SANTINI GINO | Insider | Exercise | $286.9K |
| May 20 | COLL COLLEGIUM PHARMACEUTICAL, INC | Freund John Gordon | Insider | Sell | $681 |
| May 13 | COLL COLLEGIUM PHARMACEUTICAL, INC | BOHLIN GAREN G | Insider | Sell | $323.5K |
| Mar 20 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dieter David | Insider | Sell | $488.1K |
| Apr 3 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dieter David | Insider | Tax withheld | $315.8K |
| Mar 5 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | Insider | Sell | $2.0M |
| Dec 10 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | Insider | Sell | $847.9K |
| Dec 9 | COLL COLLEGIUM PHARMACEUTICAL, INC | Balice-Gordon Rita J. | Insider | Sell | $171.7K |
| Nov 7 | COLL COLLEGIUM PHARMACEUTICAL, INC | Tupper Colleen | Insider | Sell | $1.2M |
| Sep 3 | COLL COLLEGIUM PHARMACEUTICAL, INC | Smith Thomas B | EVP and Chief Medical Officer | Sell | $671.6K |
| Aug 20 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $626.2K |
| Aug 19 | COLL COLLEGIUM PHARMACEUTICAL, INC | SANTINI GINO | Director | Sell | $201.0K |
| Aug 15 | COLL COLLEGIUM PHARMACEUTICAL, INC | Rubric Capital Management LP | 10% Owner | Sell | $946.3K |
| Aug 15 | COLL COLLEGIUM PHARMACEUTICAL, INC | Dreyer Scott | EVP & Chief Commercial Officer | Sell | $184.9K |
| Aug 12 | COLL COLLEGIUM PHARMACEUTICAL, INC | Freund John Gordon | Director | Sell | $400.6K |
| Aug 15 | COLL COLLEGIUM PHARMACEUTICAL, INC | Rubric Capital Management LP | 10% Owner | Other | $0 |
16 filings